IPCA Laboratories has informed that the meeting of the Board of Directors of the Company is scheduled on 13/11/2021 to consider and approve the Standalone and Consolidated Unaudited financial results for the period ended September 30, 2021, Interim dividend, and sub-division of every 1 equity share of the nominal/face value of Rs 2 each into 2 equity shares of the nominal/face value of Re 1 each.
The above information is a part of company’s filings submitted to BSE.